| Literature DB >> 35216587 |
Ufuk Yildirim1, Murat Akcay2, Metin Coksevim2, Ercan Turkmen3, Okan Gulel2.
Abstract
BACKGROUND: Renal transplantation (RT) has been demonstrated to improve left ventricular systolic function. However, only few studies have attempted to reveal the effects of transplantation on left atrial (LA) function. In our study, we aimed to compare LA function between RT and hemodialysis patients.Entities:
Keywords: Hemodialysis; Left atrial function; Renal transplantation; Speckle tracking echocardiography; Strain; Strain rate
Mesh:
Year: 2022 PMID: 35216587 PMCID: PMC8881848 DOI: 10.1186/s12947-022-00275-4
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
Fig. 1Left atrial strain curves. LASr, left atrial strain during reservoir phase; LAScd, left atrial strain during conduit phase; LASct, left atrial strain during contraction phase
Fig. 2Left atrial strain rate curves. pLASRr, left atrial peak strain rate during reservoir phase; pLASRcd, left atrial peak strain rate during conduit phase; pLASRct, left atrial peak strain rate during contraction phase
Left atrial deformation parameters
| Variable | Transplantation group | Hemodialysis group | ||
|---|---|---|---|---|
| LASr (%) | 29.88 ± 5.76 | 26.11 ± 5.74 | ||
| LAScd (%) | −15.28 ± 5.00 | −12.92 ± 4.38 | ||
| LASct (%) | − 14.60 ± 3.32 | −13.19 ± 3.95 | .274 | |
| pLASRr (s−1) | 1.54 ± 0.33 | 1.32 ± 0.33 | ||
| pLASRcd (s−1) | − 1.47 ± 0.49 | −1.12 ± 0.42 | ||
| pLASRct (s−1) | −2.13 ± 0.46 | −1.83 ± 0.58 | .076 |
*After adjustment for SBP, serum hemoglobin level, and LVEF
Baseline characteristics of the study population
| Variable | Transplantation group | Hemodialysis group | |
|---|---|---|---|
| Age (year) | 41.3 ± 10.5 | 43.3 ± 10.6 | .257 |
| Male (%a) | 39 (52.0) | 37 (49.3) | .870 |
| SBP (mmHg) | 123.5 ± 15.0 | 133.2 ± 17.5 | |
| DBP (mmHg) | 78.2 ± 9.2 | 80.4 ± 10.2 | .167 |
| Heart rate (beats/min) | 80.3 ± 11.7 | 79.3 ± 13.1 | .637 |
| History of hypertension (%a) | 58 (77.3) | 64 (85.3) | .295 |
| Duration of hypertension (year) | 8 (1–20) | 8 (1–25) | .429 |
| History of diabetes mellitus (%a) | 13 (17.3) | 14 (18.7) | .832 |
| Duration of diabetes mellitus (year) | 9.0 ± 5.9 | 12.7 ± 6.8 | .142 |
| Duration of CKD (year) | 10 (3–25) | 7 (1–24) | |
| Serum hemoglobin level (g/dL) | 13.71 ± 1.84 | 12.02 ± 1.50 |
aColumn percentage
Standard echocardiographic parameters
| Variable | Transplantation group | Hemodialysis group | |
|---|---|---|---|
| LVDD (mm) | 43 (36–58) | 48 (34–58) | |
| LVSD (mm) | 26 (19–43) | 32 (19–45) | |
| SWT (mm) | 12 (7–17) | 13 (7–17) | |
| PWT (mm) | 10 (7–15) | 12 (7–17) | |
| LVMi (g/m2) | 96.8 ± 25.2 | 130.5 ± 41.2 | |
| LVEF (%) | 66.6 ± 5.7 | 59.8 ± 6.5 | |
| LAAPD (mm) | 33 (26–45) | 37 (25–45) | |
| LAVi (mL/m2) | 23 (13–55) | 34 (13–60) | |
| Mitral E (cm/s) | 83.7 ± 19.8 | 88.3 ± 25.1 | .219 |
| Mitral A (cm/s) | 79.9 ± 16.6 | 90.0 ± 18.0 | |
| Mitral E/A | 1.1 (0.5–1.6) | 0.9 (0.5–1.6) | .070 |
| Mitral s’ (cm/s) | 9 (6–15) | 7 (5–12) | |
| Mitral e’ (cm/s) | 10.1 ± 3.0 | 8.4 ± 2.7 | |
| Mitral a’ (cm/s) | 10 (7–18) | 9 (5–17) | |
| Mitral E/e’ | 8.1 (4.7–18.0) | 10.8 (4.2–24.5) | |
| PASP (mmHg) | 26.9 ± 6.8 | 28.3 ± 7.7 | .229 |
Correlation analysis
| Variable | LASr | LAScd | LASct | pLASRr | pLASRcd | pLASRct | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R | R | R | R | R | R | |||||||
| LVDD | −.139 | .093 | −.002 | .977 | −.269 | −.187 | −.164 | −.260 | ||||
| LVSD | −.238 | −.085 | .304 | −.328 | −.197 | −.215 | −.349 | |||||
| SWT | −.241 | −.294 | .002 | .984 | −.227 | −.418 | −.117 | .158 | ||||
| PWT | −.333 | −.345 | −.099 | .230 | −.312 | −.506 | −.233 | |||||
| LVMi | −.315 | −.230 | −.214 | −.357 | −.402 | −.270 | ||||||
| LVEF | .262 | .123 | .138 | .309 | .160 | .052 | .179 | .326 | ||||
| LAAPD | −.324 | −.214 | −.282 | −.322 | −.419 | −.362 | ||||||
| LAVi | −.327 | −.212 | −.292 | −.357 | −.404 | −.421 | ||||||
| Mitral E | .154 | .062 | .294 | −.213 | −.120 | .146 | .208 | −.204 | ||||
| Mitral A | .009 | .913 | −.109 | .187 | .174 | .053 | .525 | −.238 | .056 | .500 | ||
| Mitral E/A | .119 | .149 | .355 | −.337 | −.158 | .056 | .366 | −.237 | ||||
| Mitral s’ | .369 | .371 | .130 | .116 | .486 | .464 | .336 | |||||
| Mitral e’ | .608 | .674 | .112 | .176 | .418 | .766 | .313 | |||||
| Mitral a’ | .162 | −.072 | .382 | .413 | .408 | −.049 | .554 | .459 | ||||
| Mitral E/e’ | −.413 | −.390 | −.172 | −.451 | −.498 | −.395 | ||||||
| PASP | −.090 | .276 | −.037 | .653 | −.098 | .235 | −.253 | −.121 | .144 | −.137 | .097 | |
Intraobserver and interobserver variability
| Variable | Intraobserver variation | Interobserver variation | ||||
|---|---|---|---|---|---|---|
| ICC | 95% CI | ICC | 95% CI | |||
| LASr | 0.987 | 0.955–0.996 | 0.985 | 0.947–0.996 | ||
| LAScd | 0.978 | 0.924–0.994 | 0.960 | 0.862–0.989 | ||
| LASct | 0.966 | 0.882–0.990 | 0.973 | 0.905–0.992 | ||
| pLASRr | 0.938 | 0.786–0.982 | 0.893 | 0.628–0.969 | ||
| pLASRcd | 0.991 | 0.969–0.997 | 0.979 | 0.928–0.994 | ||
| pLASRct | 0.957 | 0.852–0.988 | 0.970 | 0.895–0.991 | ||
CI Confidence interval